 IDEAYA Biosciences, Inc. NASDAQ:IDYA, an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics based on Synthetic Lethality, announced the appointment of Garret Hampton, Ph.D., to its Board of Directors. 